Know Cancer

or
forgot password

Descriptive Pharmacoepidemiological Study of Patients Treated With Iressa


N/A
N/A
N/A
Open (Enrolling)
Both
Lung Cancer

Thank you

Trial Information

Descriptive Pharmacoepidemiological Study of Patients Treated With Iressa


Descriptive pharmacoepidemiological study of patients treated with Iressa


Inclusion Criteria:



- Patients treated with Iressa

Exclusion Criteria:

- Patient included in a therapeutic trial comprising protocol use of Iressa

- Patient included in a therapeutic trial (Huriet-Serusclat Act)

- Patient refusing to participate in the study

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

The Overall survival

Outcome Time Frame:

24 months

Safety Issue:

Yes

Principal Investigator

Thierry BOUILLET, Dr

Investigator Role:

Principal Investigator

Investigator Affiliation:

Bobigny

Authority:

France: French Data Protection Authority

Study ID:

NIS-OFR-IRE-2011/1

NCT ID:

NCT01448187

Start Date:

January 2012

Completion Date:

January 2015

Related Keywords:

  • Lung Cancer
  • Lung cancer, France
  • Lung Neoplasms

Name

Location